APA

Atzpodien J., Kirchner H., Rebmann U., Soder M., Gertenbach U., Siebels M., Roigas J., Raschke R., Salm S., Schwindl B., Müller S. C., Hauser S., Leiber C., Huland E., Heinzer H., Siemer S., Metzner B., Heynemann H., Fornara P. & Reitz M. (20060915). Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). : British journal of cancer.

Chicago

Atzpodien J, Kirchner H, Rebmann U, Soder M, Gertenbach U, Siebels M, Roigas J, Raschke R, Salm S, Schwindl B, Müller S C, Hauser S, Leiber C, Huland E, Heinzer H, Siemer S, Metzner B, Heynemann H, Fornara P and Reitz M. 20060915. Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). : British journal of cancer.

Harvard

Atzpodien J., Kirchner H., Rebmann U., Soder M., Gertenbach U., Siebels M., Roigas J., Raschke R., Salm S., Schwindl B., Müller S. C., Hauser S., Leiber C., Huland E., Heinzer H., Siemer S., Metzner B., Heynemann H., Fornara P. and Reitz M. (20060915). Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). : British journal of cancer.

MLA

Atzpodien J, Kirchner H, Rebmann U, Soder M, Gertenbach U, Siebels M, Roigas J, Raschke R, Salm S, Schwindl B, Müller S C, Hauser S, Leiber C, Huland E, Heinzer H, Siemer S, Metzner B, Heynemann H, Fornara P and Reitz M. Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). : British journal of cancer. 20060915.